Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic Melanoma
Clinical trial NCT02308553 · COMPLETED
Trial details
- NCT number
- NCT02308553
- Sponsor
- Prof. Dr. med. Dirk Schadendorf
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-17
- Primary completion
- 2019-10-17
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.